Dr. Falk Pharma GmbH

Quick facts

Marketed products

• high dose budesonide tablet
• low dose budesonide tablet

Phase 3 pipeline

• mesalamine granules · Gastroenterology
  Mesalamine works by releasing aminosalicylates in the colon to reduce inflammation and prevent symptoms of ulcerative colitis.
• norUrsodeoxycholic acid · Liver disease
  NorUrsodeoxycholic acid is a bile acid that acts as an FXR agonist.
• Placebo orodispersible tablet twice daily
  This drug is a placebo, meaning it has no active therapeutic effect.

Phase 2 pipeline

• High dose TSO · Infectious Disease
  Treats Cryptococcal meningitis by inhibiting the cell wall synthesis of Cryptococcus neoformans
• Medium dose TSO
• Mesalamine Oral Product
• norUDCA
• ZED1227

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Dr. Falk Pharma GmbH portfolio CI brief
• Dr. Falk Pharma GmbH pipeline updates RSS